daunorubicin has been researched along with Left Ventricular Dysfunction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhter, N; Altman, JK; Canaani, J; Cascino, GJ; Foran, JM; Furiasse, N; Ky, B; Litzow, MR; Luger, S; Rademaker, A; Rigolin, V; Tallman, MS; Voss, WB | 1 |
| Adamcová, M; Holečková, M; Jirkovská, A; Karabanovich, G; Kocúrová-Lengvarská, J; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Roh, J; Šimůnek, T; Štěrba, M; Štěrbová-Kovaříková, P; Váňová, N | 1 |
| Babaoğlu, K; Başar, EZ; Çetin, S; Çorapçıoğlu, F; Deveci, M | 1 |
| Bonkovsky, HL; D'Agostino, RB; Hundley, WG; Jordan, JH; Lamar, ZS; Meléndez, GC; Poole, LB; Porosnicu, M; Vera, T; Whitlock, MC | 1 |
| Gietema, JA; Postma, A; van den Berg, MP; van Spaendonck-Zwarts, KY; van Tintelen, JP; van Veldhuisen, DJ | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Klimtová, I; Mazurová, Y; Simůnek, T | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Simůnek, T; Sterba, M | 1 |
| de Camargo, B; Deheinzelin, D; Junior, SP; Lopes, LF; Santin, JC | 1 |
| Barron, JT; Ghalie, R; Kaizer, H; Kakavas, PW; Parrillo, JE | 1 |
| Huang, GY; Lau, J; Li, CK; Oppenheimer, SJ; Shing, MK; Sung, RY; Yuen, MP | 1 |
1 trial(s) available for daunorubicin and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cardiotoxicity; Clofarabine; Cytarabine; Daunorubicin; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Retrospective Studies; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2019 |
9 other study(ies) available for daunorubicin and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Chronic Disease; Daunorubicin; Diketopiperazines; Disease Models, Animal; DNA Damage; Fibrosis; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Prodrugs; Rabbits; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Topics: Adolescent; Adult; Anthracyclines; Antibiotics, Antineoplastic; Cancer Survivors; Cardiotoxicity; Child; Child, Preschool; Daunorubicin; Doxorubicin; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Neoplasms; Prospective Studies; Ventricular Dysfunction, Left; Young Adult | 2018 |
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bilirubin; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Hematologic Neoplasms; Humans; Idarubicin; Male; Middle Aged; Oxidative Stress; Retrospective Studies; Stroke Volume; Ventricular Dysfunction, Left | 2015 |
Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
Topics: Adult; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Cardiotoxins; Daunorubicin; Doxorubicin; Genetic Predisposition to Disease; Humans; Male; Neoplasms; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Clinical Chemistry Tests; Daunorubicin; Disease Models, Animal; Doxorubicin; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Kidney; Male; Myocardium; Rabbits; Toxicity Tests, Chronic; Ventricular Dysfunction, Left | 2002 |
Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Chinchilla; Daunorubicin; Male; Myocardial Contraction; Myocardium; Rabbits; Troponin T; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Daunorubicin; Diastole; Doxorubicin; Echocardiography; Female; Humans; Male; Neoplasms; Systole; Ventricular Dysfunction, Left | 2007 |
Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Echocardiography, Doppler, Color; Enalapril; Female; Gated Blood-Pool Imaging; Heart Failure; Humans; Idarubicin; Leukemia; Male; Middle Aged; Radiation Injuries; Radiotherapy; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Diastole; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart; Heart Ventricles; Humans; Male; Neoplasms; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 1997 |